A clinician at University Hospitals Plymouth NHS Trust has been awarded a prestigious fellowship aimed at advancing treatments for brain tumours, marking a significant development in neuro-oncology research. Dr Sarah Kingdon, who recently completed her clinical oncology training, is the inaugural recipient of the Tessa Jowell Fellowship, a joint initiative by the Tessa Jowell Brain Cancer Mission and the Chief Scientist Office of Scotland. This fellowship not only signifies individual achievement but also represents a collaborative effort to improve patient care for brain tumour sufferers.

Dr Kingdon's fellowship is co-funded by both the Beatson Cancer Charity and NHS Lothian Charity, reflecting a commitment to enhancing brain cancer treatment and research in Scotland. Her work will take place between the Beatson West of Scotland Cancer Centre and the Edinburgh Cancer Centre. Currently based in Plymouth, Dr Kingdon began her journey at the NHS Trust in 2017 and has progressively moved through various roles before specialising in clinical oncology. Her enthusiasm for the fellowship was evident when she reflected on the opportunity, stating, “I was really excited at the opportunity when they offered it to me.”

With over 12,000 people diagnosed with primary brain tumours annually in the UK—approximately half of which are cancerous—the urgency for advanced treatment methods cannot be underestimated. Current statistics indicate that the five-year survival rate for these tumours remains relatively low, highlighting a critical need for innovative therapies. The year-long fellowship is designed to deepen Dr Kingdon's understanding of brain tumour management and enhance her research capabilities through involvement in neuro-oncology clinical trials. These trials are anticipated to pave new avenues for patient treatment and improve overall outcomes.

As part of her fellowship, Dr Kingdon will benefit from guidance and support from a multitude of renowned consultants across her new locations in Scotland. She noted that this exposure would allow her to observe varied clinical practices that could ultimately influence her approach upon returning to UHP as a consultant in 2026. “This will enable us to signpost our patients in the southwest to national clinical trials and treatments," she expressed, indicating a vision for broader collaboration across regions. Dr Kingdon’s experiences will also contribute to building a professional network, enabling future partnerships that could enhance service delivery for patients in the southwest.

Moreover, the Tessa Jowell Fellowships Programme marks a transformative chapter not only for Dr Kingdon but for the entire field of neuro-oncology in Scotland. The partnership that funds these fellowships aims to bolster the infrastructure supporting brain tumour research and therapeutic innovation, making a concerted effort to address the needs of a patient demographic affected across all age groups. As brain tumours can be diagnosed in children and are notably prevalent among older adults, the initiative reflects a holistic approach toward treatment and research.

Dr Kingdon’s fellowship is a promising step forward in a field where advancements can lead to significant shifts in patient outcomes, offering hope and a renewed sense of purpose in the ongoing battle against brain tumours.

📌 Reference Map:

Source: Noah Wire Services